Saman Rezazadeh

KN-93 (2-[N-(2-Hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor, Is a Direct Extracellular Blocker of Voltage-Gated Potassium Channels

Saman Rezazadeh, Tom W. Claydon, David Fedida · Journal of Pharmacology and Experimental Therapeutics · 2006 · 122 citations

Natural Sciences, Biochemistry, Pharmacology +17

Rb+ Flux through hERG Channels Affects the Potency of Channel Blocking Drugs: Correlation with Data Obtained Using a High-Throughput Rb+ Efflux Assay

Saman Rezazadeh, J. Christian Hesketh, David Fedida · SLAS DISCOVERY · 2004 · 60 citations · Full text

Medicine, Biophysics, Pharmacology +17

Mutations within the S4–S5 Linker Alter Voltage Sensor Constraints in hERG K+ Channels

Aaron C. Van Slyke, Saman Rezazadeh, Mischa Snopkowski et al. · Biophysical Journal · 2010 · 58 citations · Full text

Natural Sciences, Biochemistry, Molecular Biology +11

Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathy

Andreas Brodehl, Saman Rezazadeh, Tatjana Williams et al. · Translational research · 2019 · 45 citations · Full text

Medicine, Cardiology, Molecular Genetics +14

A KCNQ1 V205M missense mutation causes a high rate of long QT syndrome in a First Nations community of northern British Columbia: a community-based approach to understanding the impact

Laura Arbour, Saman Rezazadeh, Jodene Eldstrom et al. · Genetics in Medicine · 2008 · 44 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11